Press Release | November 9, 2016
BIO President and CEO Jim Greenwood released the following statement today regarding the FDA’s hearing on product communications:“In the era of data-driven medicine, where all parties seek more, not less, information about the safety, effectiveness, and value of treatments, fostering informed…